A single dose of the human papillomavirus vaccine is highly effective at preventing infections over three years, most likely lowering rates of cervical cancer and other diseases linked to the virus, according to a new study in Kenya.A single-dose strategy would dramatically extend supplies of the vaccine, lower costs and simplify distribution, which would make…
